XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION GRANTED

During the three and six months ended June 30, 2024 and 2023, the Company granted stock options to purchase the number of shares of the Company’s common stock set forth in the table below (in thousands):

 

   2024   2023   2024   2023 
   Three months ended June 30,   Six months ended June 30, 
   2024   2023   2024   2023 
Stock options granted   501    25    2,375    237 
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS USED FOR STOCK OPTIONS GRANTED

The following weighted-average assumptions were used for stock options granted during the three and six months ended June 30, 2024 and 2023:

 

ixbrl  2024   2023   2024   2023 
   Three months ended June 30,   Six months ended June 30, 
   2024   2023   2024   2023 
Weighted average risk-free rate   4.32%   3.54%   4.45%   3.82%
Weighted average volatility   91.77%   96.09%   97.91%   95.15%
Dividend yield   0.00%   0%   0%   0%
Expected term   5.68 years    6.08 years    5.85 years    5.44 years 
SCHEDULE OF WEIGHTED AVERAGE GRANT-DATE FAIR VALUE OF STOCK OPTIONS

The per-share weighted average grant-date fair value of stock options granted during the three and six months ended June 30, 2024 and 2023 were as follows:

 

   2024   2023   2024   2023 
   Three months ended June 30,   Six months ended June 30, 
   2024   2023   2024   2023 
Weighted average grant date fair value  $1.42   $1.64   $1.44   $2.99 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

For the three and six months ended June 30, 2024 and 2023, the Company recognized stock-based compensation expense as follows (in thousands):

 

   2024   2023   2024   2023 
   Three months ended June 30,   Six months ended June 30, 
   2024   2023   2024   2023 
Research and development  $15   $56   $61   $120 
General and administrative   408    158    644    783 
Total  $423   $214   $705   $903